In patients with cholangiocarcinoma, surgical resection with curative intent is the only way to achieve cure. Since surgical resection of cholangiocarcinomas is technically demanding, determination of resectability and accurate preoperative staging are crucial. For these purposes, high quality imaging including multidetector computed tomography and magnetic resonance imaging with magnetic resonance cholangiopancreaticography, is mandatory. This article will present recent advances in imaging techniques for cholangiocarginomas, potential pitfalls in imaging evaluation, and a checklist for preoperative radiologic assessment of resectability in these patients with an emphasis on perihilar cholangiocarinoma. (Korean J Gastroenterol 2017;69:159-163) 
INTRODUCTION
Cholangiocarcinoma (CCA) is an epithelial cell malignancy arising from varying locations within the biliary tree showing markers of cholangiocyte differentiation. 1 Most CCAs are adenocarcinomas which tend to develop desmoplastic reactions and early perineural invasion. 2 CCA can be classified according to its morphology and anatomic location. Based on its anatomic location, CCA is classified as intrahepatic CCA (iCCA), perihilar CCA (pCCA), and distal CCA (dCCA). CCA exhibits three growth patterns: mass-forming (MF), periductal infiltrating (IF), and intraductal growing. The MF type is the most common form of iCCA, representing 86% of them, while the majority of pCCA and dCCA is the periductal IF type. 3 This classification can be helpful in determining treatment options and optimal imaging modalities. iCCA frequently requires hemihepatectomy or sectionectomy for resection of the tumors, whereas dCCA is treated with Whipple's operation or pylorus preserving pancreatoduodenectomy. 4 For pCCA, resection of the involved intrahepatic and extrahepatic bile ducts as well as the ipsilateral liver is the standard surgical treatment. 5 In addition, different macroscopic growth patterns can be associated with the mode of spread, which should be considered during preoperative evaluation.
Submucosal extension is commonly seen in IF type CCA, while mucosal spread frequently occurs in intraductal growing type CCA.
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The Korean Journal of Gastroenterology Fig. 1) . 9 According to a recent meta-analysis, the accuracy of ductal involvement of MDCT was 86%, 11 while
MDCT significantly underestimates longitudinal extent. 12 It showed 84% sensitivity and 93% specificity to detect hepatic arterial involvement. 11 The accuracy for detection of portal vein has been reported as 87%. 13 Regarding lymph node metastasis, the sensitivity was 61% and the specificity was 88%. Of note, imaging studies are supposed to be obtained before biliary drainage, as the lesion can be obscured by the inserted drainage catheter. Moreover, biliary stent insertion can cause mural thickening and enhancement mimicking the tumor spread due to postinverventional inflammatory changes, which may cause overstaging of disease extent particularly on MR imaging. 15, 28 If imaging is performed after biliary drainage, radiologists should be careful not to overestimate the tumor extent (Fig. 2) .
Biliary obstruction is frequently present in patients with pCCA or dCCA. 29 In this circumstance, liver abscesses can develop manifesting as peripheral enhancing lesions in the liver, which resembles the appearances of intrahepatic metastases. Even though some previous work suggested imaging features on MR imaging differentiating hepatic abscesses from metastases, 30 it is challenging to distinguish these two conditions particularly when the lesions are small.
In some confusing cases, follow-up imaging after biliary drainage could be a solution.
Staging systems and resectability for pCCA
The surgical resection of pCCA is technically demanding, and various staging system for preoperative staging have been propounded over the decades. The modified Bismuth-Corlette system is commonly used to describe the proximal tumor extent. 31 However, there are limitations in determining resectability of pCCA based on the modified Bismuth-Corlette system, as it does not describe the lateral extension of the tumor nor consider variation in biliary anatomy. The Blumgart group at the Memorial Sloan-Kettering Cancer Center suggested a system to describe not only the proximal tumor extent, but also portal venous invasion and hepatic lobar atrophy which are important factors in determining resectability. 32 However, this system does not evaluate the presence of nodal or distant metastases. Recently, a new system reporting the size of the tumor, the extent of the disease in the biliary system, the involvement of the hepatic artery and portal vein, the involvement of lymph nodes, distant metastases, and the volume of the putative remnant liver after resection, was
proposed. 33 To test the validity and further refinement of this system, further study is warranted.
The standard of treatment for surgical candidate with pCCA is resection of the involved intrahepatic and extrahepatic bile ducts as well as the ipsilateral liver. 5 
